News

Fierce Biotech43m
Lilly preps oral GLP-1 for regulatory review after phase 3 shows 12% weight loss
As other pharmas drop next-gen obesity assets, Eli Lilly’s experimental oral GLP-1 has prompted weight loss up to an average ...
Lilly: Q2 Earnings Snapshot
Earnings, adjusted for one-time gains and costs, came to $6.31 per share. The results surpassed Wall Street expectations. The ...
These Stocks Are Moving the Most Today: Fortinet, AppLovin, Eli Lilly, Airbnb, Duolingo, and More
Fortinet, AppLovin, Airbnb, Duolingo and more stock were making big moves Thursday after the companies reported quarterly ...
The Daily Reporter12h
Eli Lilly and Co. could get $100 million in state tax credits
Eli Lilly is eligible for 100M in tax credits to expand its Pleasant Prairie facility, adding 750 jobs and boosting Wisconsin ...
Lilly reports second-quarter 2025 financial results and raises guidance
Eli Lilly and Company (NYSE: LLY) today announced its financial results for the second quarter of 2025. "Lilly delivered another quarter ...
Eli Lilly Earnings, Fed Speakers, Bank of England Rate Decision: Still to Come This Week
Earnings season marches on, with Eli Lilly among the big names yet to report this week. President Trump has said he will name replacements this week for Federal Reserve governor Adriana Kugler and [Bu ...
Jim Cramer Shows Concerns That Eli Lilly “Might Be a Little Diluted”
Eli Lilly and Company (NYSE:LLY) is one of the stocks in Jim Cramer’s game plan for this week. Cramer highlighted that his ...
Hosted on MSN2h
Nasdaq, S&P 500 Futures Climb Despite Trump Tariff Rollout — Spotlight On Jobs Data, Eli Lilly, Warner Bros. Earnings
U.S. stock futures strengthened early Thursday, despite a tariff threat looming large. President Donald Trump confirmed by ...